Global Drug Repurposing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 46244
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Drug Repurposing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Drug Repurposing size is estimated to be USD 28210 million in 2026 from USD 25280 million in 2020, with a change XX% between 2020 and 2021. The global Drug Repurposing market size is expected to grow at a CAGR of 2.8% for the next five years.

Market segmentation

Drug Repurposing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Oncology

CNS Diseases

Neurodegenerative Diseases

Others

Market segment by Application, can be divided into

Hospitals

Ambulatory Surgical Centers

Others

Market segment by players, this report covers

Astellas Pharma

Biovista

Novartis

AbbVie

Pfizer

Allergan

NuMedii

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Drug Repurposing product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Drug Repurposing, with revenue, gross margin and global market share of Drug Repurposing from 2019 to 2021.

Chapter 3, the Drug Repurposing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Drug Repurposing market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Drug Repurposing research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Drug Repurposing

1.2 Classification of Drug Repurposing by Type

1.2.1 Overview: Global Drug Repurposing Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Drug Repurposing Revenue Market Share by Type in 2020

1.2.3 Oncology

1.2.4 CNS Diseases

1.2.5 Neurodegenerative Diseases

1.2.6 Others

1.3 Global Drug Repurposing Market by Application

1.3.1 Overview: Global Drug Repurposing Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Others

1.4 Global Drug Repurposing Market Size & Forecast

1.5 Global Drug Repurposing Market Size and Forecast by Region

1.5.1 Global Drug Repurposing Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Drug Repurposing Market Size by Region, (2016-2021)

1.5.3 North America Drug Repurposing Market Size and Prospect (2016-2026)

1.5.4 Europe Drug Repurposing Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Drug Repurposing Market Size and Prospect (2016-2026)

1.5.6 South America Drug Repurposing Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Drug Repurposing Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Drug Repurposing Market Drivers

1.6.2 Drug Repurposing Market Restraints

1.6.3 Drug Repurposing Trends Analysis

2 Company Profiles

2.1 Astellas Pharma

2.1.1 Astellas Pharma Details

2.1.2 Astellas Pharma Major Business

2.1.3 Astellas Pharma Drug Repurposing Product and Solutions

2.1.4 Astellas Pharma Drug Repurposing Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Astellas Pharma Recent Developments and Future Plans

2.2 Biovista

2.2.1 Biovista Details

2.2.2 Biovista Major Business

2.2.3 Biovista Drug Repurposing Product and Solutions

2.2.4 Biovista Drug Repurposing Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Biovista Recent Developments and Future Plans

2.3 Novartis

2.3.1 Novartis Details

2.3.2 Novartis Major Business

2.3.3 Novartis Drug Repurposing Product and Solutions

2.3.4 Novartis Drug Repurposing Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Novartis Recent Developments and Future Plans

2.4 AbbVie

2.4.1 AbbVie Details

2.4.2 AbbVie Major Business

2.4.3 AbbVie Drug Repurposing Product and Solutions

2.4.4 AbbVie Drug Repurposing Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 AbbVie Recent Developments and Future Plans

2.5 Pfizer

2.5.1 Pfizer Details

2.5.2 Pfizer Major Business

2.5.3 Pfizer Drug Repurposing Product and Solutions

2.5.4 Pfizer Drug Repurposing Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Pfizer Recent Developments and Future Plans

2.6 Allergan

2.6.1 Allergan Details

2.6.2 Allergan Major Business

2.6.3 Allergan Drug Repurposing Product and Solutions

2.6.4 Allergan Drug Repurposing Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Allergan Recent Developments and Future Plans

2.7 NuMedii

2.7.1 NuMedii Details

2.7.2 NuMedii Major Business

2.7.3 NuMedii Drug Repurposing Product and Solutions

2.7.4 NuMedii Drug Repurposing Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 NuMedii Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Drug Repurposing Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Drug Repurposing Players Market Share

3.2.2 Top 10 Drug Repurposing Players Market Share

3.2.3 Market Competition Trend

3.3 Drug Repurposing Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Drug Repurposing Revenue and Market Share by Type (2016-2021)

4.2 Global Drug Repurposing Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Drug Repurposing Revenue Market Share by Application (2016-2021)

5.2 Drug Repurposing Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Drug Repurposing Revenue by Type (2016-2026)

6.2 North America Drug Repurposing Revenue by Application (2016-2026)

6.3 North America Drug Repurposing Market Size by Country

6.3.1 North America Drug Repurposing Revenue by Country (2016-2026)

6.3.2 United States Drug Repurposing Market Size and Forecast (2016-2026)

6.3.3 Canada Drug Repurposing Market Size and Forecast (2016-2026)

6.3.4 Mexico Drug Repurposing Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Drug Repurposing Revenue by Type (2016-2026)

7.2 Europe Drug Repurposing Revenue by Application (2016-2026)

7.3 Europe Drug Repurposing Market Size by Country

7.3.1 Europe Drug Repurposing Revenue by Country (2016-2026)

7.3.2 Germany Drug Repurposing Market Size and Forecast (2016-2026)

7.3.3 France Drug Repurposing Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Drug Repurposing Market Size and Forecast (2016-2026)

7.3.5 Russia Drug Repurposing Market Size and Forecast (2016-2026)

7.3.6 Italy Drug Repurposing Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Drug Repurposing Revenue by Type (2016-2026)

8.2 Asia-Pacific Drug Repurposing Revenue by Application (2016-2026)

8.3 Asia-Pacific Drug Repurposing Market Size by Region

8.3.1 Asia-Pacific Drug Repurposing Revenue by Region (2016-2026)

8.3.2 China Drug Repurposing Market Size and Forecast (2016-2026)

8.3.3 Japan Drug Repurposing Market Size and Forecast (2016-2026)

8.3.4 South Korea Drug Repurposing Market Size and Forecast (2016-2026)

8.3.5 India Drug Repurposing Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Drug Repurposing Market Size and Forecast (2016-2026)

8.3.7 Australia Drug Repurposing Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Drug Repurposing Revenue by Type (2016-2026)

9.2 South America Drug Repurposing Revenue by Application (2016-2026)

9.3 South America Drug Repurposing Market Size by Country

9.3.1 South America Drug Repurposing Revenue by Country (2016-2026)

9.3.2 Brazil Drug Repurposing Market Size and Forecast (2016-2026)

9.3.3 Argentina Drug Repurposing Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Drug Repurposing Revenue by Type (2016-2026)

10.2 Middle East & Africa Drug Repurposing Revenue by Application (2016-2026)

10.3 Middle East & Africa Drug Repurposing Market Size by Country

10.3.1 Middle East & Africa Drug Repurposing Revenue by Country (2016-2026)

10.3.2 Turkey Drug Repurposing Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Drug Repurposing Market Size and Forecast (2016-2026)

10.3.4 UAE Drug Repurposing Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Drug Repurposing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Drug Repurposing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Drug Repurposing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Drug Repurposing Revenue (USD Million) by Region (2016-2021)

Table 5. Global Drug Repurposing Revenue Market Share by Region (2021-2026)

Table 6. Astellas Pharma Corporate Information, Head Office, and Major Competitors

Table 7. Astellas Pharma Major Business

Table 8. Astellas Pharma Drug Repurposing Product and Solutions

Table 9. Astellas Pharma Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Biovista Corporate Information, Head Office, and Major Competitors

Table 11. Biovista Major Business

Table 12. Biovista Drug Repurposing Product and Solutions

Table 13. Biovista Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Novartis Corporate Information, Head Office, and Major Competitors

Table 15. Novartis Major Business

Table 16. Novartis Drug Repurposing Product and Solutions

Table 17. Novartis Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. AbbVie Corporate Information, Head Office, and Major Competitors

Table 19. AbbVie Major Business

Table 20. AbbVie Drug Repurposing Product and Solutions

Table 21. AbbVie Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Pfizer Corporate Information, Head Office, and Major Competitors

Table 23. Pfizer Major Business

Table 24. Pfizer Drug Repurposing Product and Solutions

Table 25. Pfizer Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Allergan Corporate Information, Head Office, and Major Competitors

Table 27. Allergan Major Business

Table 28. Allergan Drug Repurposing Product and Solutions

Table 29. Allergan Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. NuMedii Corporate Information, Head Office, and Major Competitors

Table 31. NuMedii Major Business

Table 32. NuMedii Drug Repurposing Product and Solutions

Table 33. NuMedii Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Global Drug Repurposing Revenue (USD Million) by Players (2019-2021)

Table 35. Global Drug Repurposing Revenue Share by Players (2019-2021)

Table 36. Breakdown of Drug Repurposing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 37. Drug Repurposing Players Head Office, Products and Services Provided

Table 38. Drug Repurposing Mergers & Acquisitions in the Past Five Years

Table 39. Drug Repurposing New Entrants and Expansion Plans

Table 40. Global Drug Repurposing Revenue (USD Million) by Type (2016-2021)

Table 41. Global Drug Repurposing Revenue Share by Type (2016-2021)

Table 42. Global Drug Repurposing Revenue Forecast by Type (2021-2026)

Table 43. Global Drug Repurposing Revenue by Application (2016-2021)

Table 44. Global Drug Repurposing Revenue Forecast by Application (2021-2026)

Table 45. North America Drug Repurposing Revenue by Type (2016-2021) & (USD Million)

Table 46. North America Drug Repurposing Revenue by Type (2021-2026) & (USD Million)

Table 47. North America Drug Repurposing Revenue by Application (2016-2021) & (USD Million)

Table 48. North America Drug Repurposing Revenue by Application (2021-2026) & (USD Million)

Table 49. North America Drug Repurposing Revenue by Country (2016-2021) & (USD Million)

Table 50. North America Drug Repurposing Revenue by Country (2021-2026) & (USD Million)

Table 51. Europe Drug Repurposing Revenue by Type (2016-2021) & (USD Million)

Table 52. Europe Drug Repurposing Revenue by Type (2021-2026) & (USD Million)

Table 53. Europe Drug Repurposing Revenue by Application (2016-2021) & (USD Million)

Table 54. Europe Drug Repurposing Revenue by Application (2021-2026) & (USD Million)

Table 55. Europe Drug Repurposing Revenue by Country (2016-2021) & (USD Million)

Table 56. Europe Drug Repurposing Revenue by Country (2021-2026) & (USD Million)

Table 57. Asia-Pacific Drug Repurposing Revenue by Type (2016-2021) & (USD Million)

Table 58. Asia-Pacific Drug Repurposing Revenue by Type (2021-2026) & (USD Million)

Table 59. Asia-Pacific Drug Repurposing Revenue by Application (2016-2021) & (USD Million)

Table 60. Asia-Pacific Drug Repurposing Revenue by Application (2021-2026) & (USD Million)

Table 61. Asia-Pacific Drug Repurposing Revenue by Region (2016-2021) & (USD Million)

Table 62. Asia-Pacific Drug Repurposing Revenue by Region (2021-2026) & (USD Million)

Table 63. South America Drug Repurposing Revenue by Type (2016-2021) & (USD Million)

Table 64. South America Drug Repurposing Revenue by Type (2021-2026) & (USD Million)

Table 65. South America Drug Repurposing Revenue by Application (2016-2021) & (USD Million)

Table 66. South America Drug Repurposing Revenue by Application (2021-2026) & (USD Million)

Table 67. South America Drug Repurposing Revenue by Country (2016-2021) & (USD Million)

Table 68. South America Drug Repurposing Revenue by Country (2021-2026) & (USD Million)

Table 69. Middle East & Africa Drug Repurposing Revenue by Type (2016-2021) & (USD Million)

Table 70. Middle East & Africa Drug Repurposing Revenue by Type (2021-2026) & (USD Million)

Table 71. Middle East & Africa Drug Repurposing Revenue by Application (2016-2021) & (USD Million)

Table 72. Middle East & Africa Drug Repurposing Revenue by Application (2021-2026) & (USD Million)

Table 73. Middle East & Africa Drug Repurposing Revenue by Country (2016-2021) & (USD Million)

Table 74. Middle East & Africa Drug Repurposing Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Drug Repurposing Picture

Figure 2. Global Drug Repurposing Revenue Market Share by Type in 2020

Figure 3. Oncology

Figure 4. CNS Diseases

Figure 5. Neurodegenerative Diseases

Figure 6. Others

Figure 7. Drug Repurposing Revenue Market Share by Application in 2020

Figure 8. Hospitals Picture

Figure 9. Ambulatory Surgical Centers Picture

Figure 10. Others Picture

Figure 11. Global Drug Repurposing Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 12. Global Drug Repurposing Revenue and Forecast (2016-2026) & (USD Million)

Figure 13. Global Drug Repurposing Revenue Market Share by Region (2016-2026)

Figure 14. Global Drug Repurposing Revenue Market Share by Region in 2020

Figure 15. North America Drug Repurposing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Europe Drug Repurposing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Asia-Pacific Drug Repurposing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. South America Drug Repurposing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Middle East and Africa Drug Repurposing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Drug Repurposing Market Drivers

Figure 21. Drug Repurposing Market Restraints

Figure 22. Drug Repurposing Market Trends

Figure 23. Astellas Pharma Recent Developments and Future Plans

Figure 24. Biovista Recent Developments and Future Plans

Figure 25. Novartis Recent Developments and Future Plans

Figure 26. AbbVie Recent Developments and Future Plans

Figure 27. Pfizer Recent Developments and Future Plans

Figure 28. Allergan Recent Developments and Future Plans

Figure 29. NuMedii Recent Developments and Future Plans

Figure 30. Global Drug Repurposing Revenue Share by Players in 2020

Figure 31. Drug Repurposing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 32. Global Top 3 Players Drug Repurposing Revenue Market Share in 2020

Figure 33. Global Top 10 Players Drug Repurposing Revenue Market Share in 2020

Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 35. Global Drug Repurposing Revenue Share by Type in 2020

Figure 36. Global Drug Repurposing Market Share Forecast by Type (2021-2026)

Figure 37. Global Drug Repurposing Revenue Share by Application in 2020

Figure 38. Global Drug Repurposing Market Share Forecast by Application (2021-2026)

Figure 39. North America Drug Repurposing Sales Market Share by Type (2016-2026)

Figure 40. North America Drug Repurposing Sales Market Share by Application (2016-2026)

Figure 41. North America Drug Repurposing Revenue Market Share by Country (2016-2026)

Figure 42. United States Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Canada Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Mexico Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. Europe Drug Repurposing Sales Market Share by Type (2016-2026)

Figure 46. Europe Drug Repurposing Sales Market Share by Application (2016-2026)

Figure 47. Europe Drug Repurposing Revenue Market Share by Country (2016-2026)

Figure 48. Germany Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. France Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. United Kingdom Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Russia Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Italy Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Asia-Pacific Drug Repurposing Sales Market Share by Type (2016-2026)

Figure 54. Asia-Pacific Drug Repurposing Sales Market Share by Application (2016-2026)

Figure 55. Asia-Pacific Drug Repurposing Revenue Market Share by Region (2016-2026)

Figure 56. China Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Japan Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. South Korea Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. India Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Southeast Asia Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Australia Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South America Drug Repurposing Sales Market Share by Type (2016-2026)

Figure 63. South America Drug Repurposing Sales Market Share by Application (2016-2026)

Figure 64. South America Drug Repurposing Revenue Market Share by Country (2016-2026)

Figure 65. Brazil Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Argentina Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Middle East and Africa Drug Repurposing Sales Market Share by Type (2016-2026)

Figure 68. Middle East and Africa Drug Repurposing Sales Market Share by Application (2016-2026)

Figure 69. Middle East and Africa Drug Repurposing Revenue Market Share by Country (2016-2026)

Figure 70. Turkey Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Saudi Arabia Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. UAE Drug Repurposing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Methodology

Figure 74. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz